Price T Rowe Associates Inc Viatris Inc Transaction History

Price T Rowe Associates Inc

$883 Billion
Q2 2025

A detailed history of Price T Rowe Associates Inc transactions in Viatris Inc stock. As of the latest transaction made, Price T Rowe Associates Inc holds 78,772,616 shares of VTRS stock, worth $797 Million. This represents 0.08% of its overall portfolio holdings.

Number of Shares

78,772,616

Previous 74,461,308 5.79%

Holding current value

$797 Million

Previous $649 Million 8.46%

% of portfolio

0.08%

Previous 0.08%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	BUY	$7.26 - $9.12 $31.3 Million - $39.3 Million	4,311,308 Added 5.79%	78,772,616 $703 Million
Q1 2025 May 14, 2025	BUY	$8.68 - $12.42 $137 Million - $196 Million	15,781,561 Added 26.89%	74,461,308 $649 Million
Q4 2024 Feb 14, 2025	BUY	$11.32 - $13.37 $112 Million - $132 Million	9,894,517 Added 20.28%	58,679,747 $731 Million
Q3 2024 Nov 14, 2024	SELL	$10.32 - $12.13 $83 Million - $97.5 Million	-8,037,800 Reduced 14.15%	48,785,230 $566 Million
Q2 2024 Aug 14, 2024	SELL	$10.05 - $12.02 $10.7 Million - $12.8 Million	-1,061,401 Reduced 1.83%	56,823,030 $604 Million
Q1 2024 May 15, 2024	BUY	$11.27 - $13.53 $94.9 Million - $114 Million	8,418,678 Added 17.02%	57,884,431 $691 Million
Q4 2023 Feb 14, 2024	SELL	$8.77 - $10.85 $6.57 Million - $8.13 Million	-749,259 Reduced 1.49%	49,465,753 $536 Million
Q3 2023 Nov 14, 2023	BUY	$9.59 - $11.35 $16.5 Million - $19.5 Million	1,715,646 Added 3.54%	50,215,012 $495 Million
Q2 2023 Aug 14, 2023	BUY	$9.02 - $10.29 $65 Million - $74.2 Million	7,208,400 Added 17.46%	48,499,366 $484 Million
Q1 2023 May 15, 2023	BUY	$9.2 - $12.26 $79.9 Million - $106 Million	8,679,972 Added 26.62%	41,290,966 $397 Million
Q4 2022 Feb 14, 2023	BUY	$8.72 - $11.56 $35.2 Million - $46.7 Million	4,036,373 Added 14.13%	32,610,994 $363 Million
Q3 2022 Nov 14, 2022	BUY	$8.48 - $11.13 $229 Million - $300 Million	26,993,280 Added 1706.99%	28,574,621 $243 Million
Q2 2022 Aug 15, 2022	SELL	$9.95 - $12.27 $1.33 Million - $1.64 Million	-133,537 Reduced 7.79%	1,581,341 $16.6 Million
Q1 2022 May 16, 2022	SELL	$9.81 - $15.4 $960,457 - $1.51 Million	-97,906 Reduced 5.4%	1,714,878 $18.7 Million
Q4 2021 Feb 14, 2022	SELL	$12.09 - $14.68 $946,284 - $1.15 Million	-78,270 Reduced 4.14%	1,812,784 $24.5 Million
Q3 2021 Nov 15, 2021	SELL	$13.25 - $15.13 $556,672 - $635,656	-42,013 Reduced 2.17%	1,891,054 $25.6 Million
Q2 2021 Aug 16, 2021	SELL	$12.97 - $16.15 $201,151 - $250,470	-15,509 Reduced 0.8%	1,933,067 $27.6 Million
Q1 2021 May 17, 2021	SELL	$13.59 - $18.54 $2.3 Million - $3.14 Million	-169,291 Reduced 7.99%	1,948,576 $27.2 Million
Q4 2020 Feb 16, 2021	BUY	$14.3 - $18.74 $30.3 Million - $39.7 Million	2,117,867 New	2,117,867 $39.7 Million

Others Institutions Holding VTRS

# of Institutions

1,123

Shares Held

986M

Call Options Held

7.8M

Put Options Held

2.97M

View Full List

About Viatris Inc

Ticker VTRS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,212,669,952
Market Cap $12.3B
Description
Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...

More about VTRS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Price T Rowe Associates Inc , based on Form 13F filings with the SEC.

News

Stay updated on Price T Rowe Associates Inc with notifications on news.

Account

Price T Rowe Associates Inc Viatris Inc Transaction History